Latest SEC filings for Merck & Co., Inc. (MRK) explained in plain English: insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). Sourced directly from SEC EDGAR.
Seidman Christine E (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
GLOCER THOMAS H (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Coe Mary Ellen (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.
Merck & Co., Inc. filed its annual report with the SEC. This report includes audited financial statements, business overview, risk factors, and management discussion.
Guindo Chirfi, listed as Chief Marketing Officer at Merck & Co., Inc., reported an open-market sale of 10,000 MRK shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.
DEAN LI filed a Form 144 with the SEC indicating intent to sell MRK (Merck & Co., Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.
Li Dean Y, listed as Executive VP & President, MRL at Merck & Co., Inc., reported an open-market sale of 10,235 MRK shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.
JENNIFER ZACHARY filed a Form 144 with the SEC indicating intent to sell MRK (Merck & Co., Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.
CHIRFI GUINDO filed a Form 144 with the SEC indicating intent to sell MRK (Merck & Co., Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.
Guindo Chirfi, listed as Chief Marketing Officer at Merck & Co., Inc., reported an open-market sale of 10,000 MRK shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.
Zachary Jennifer, listed as EVP, General Counsel at Merck & Co., Inc., reported an open-market sale of 121,573 MRK shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.
RICHARD ROBERT DELUCA JR. filed a Form 144 with the SEC indicating intent to sell MRK (Merck & Co., Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.
DAVID WILLIAMS filed a Form 144 with the SEC indicating intent to sell MRK (Merck & Co., Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.
Williams David Michael, listed as EVP,Chief Info&Digital Officer at Merck & Co., Inc., reported an open-market sale of 5,000 MRK shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.
JOHANNES JACOBUS OOSTHUIZEN filed a Form 144 with the SEC indicating intent to sell MRK (Merck & Co., Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.